Computational modeling of intravitreal ranibizumab kinetics: Predicting macular drug concentration and half-life
PLOS One · 07.05.2026 · 21 (5) · e0348811
DOI: 10.1371/journal.pone.0348811 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 07.05.2026. Verfasst von Jabia Mostofa Chowdhury. Beteiligte Einrichtung: Department of Electrical Engineering, Texas A&M University-Texarkana, Texarkana, Texas, United States of America. Hauptthemen laut MEDLINE: Ranibizumab, Computer Simulation, Models, Biological, Macula Lutea. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ranibizumab is a key anti-VEGF therapeutic used to improve treatment efficacy and reduce injection frequency in neovascular retinal diseases. Because experimental pharmacokinetic data in humans are limited, computational modeling provides an effective means to predict ocular drug behavior. In this study, a three-dimensional computational model of the human eye was developed in COMSOL Multiphysics 6.3 to analyze the pharmacokinetics of ranibizumab following intravitreal injection. The model also quantified drug concentration near the macula, the primary target site for neovascular disease, and evaluated it against the minimum threshold concentration required for VEGF suppression. Fluid flow in the vitreous was represented by Darcy’s law, while drug convection and diffusion were modeled using the transport of diluted species equation. Four physiological scenarios combining vitreous state (normal vs. partially liquefied) and elimination pathways (anterior dominant vs. both routes) were simulated. Predicted intravitreal half-lives ranged from 2.7 to 4.4 days, consistent with reported human data (2.4 ~ 9 days). The model demonstrates a plausible representation of physiologically relevant ocular pharmacokinetics and provides a computational framework that may assist in exploring dosing strategies and informing the design of intravitreal drug delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Electrical Engineering, Texas A&M University-Texarkana, Texarkana, Texas, United States of America.
ORCID-Profile: Jabia Mostofa Chowdhury
Zitieren
APA
Chowdhury, J. M. (2026). Computational modeling of intravitreal ranibizumab kinetics: Predicting macular drug concentration and half-life. PLOS One, 21(5), e0348811. https://doi.org/10.1371/journal.pone.0348811
Vancouver
Chowdhury JM. Computational modeling of intravitreal ranibizumab kinetics: Predicting macular drug concentration and half-life. PLOS One. 2026;21(5):e0348811. doi:10.1371/journal.pone.0348811
BibTeX
@article{Chowdhury2026,
author = {Chowdhury, Jabia Mostofa},
title = {Computational modeling of intravitreal ranibizumab kinetics: Predicting macular drug concentration and half-life},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0348811},
doi = {10.1371/journal.pone.0348811}
}
EUVIMED